From: Salivary microbiome profiles of oral cancer patients analyzed before and after treatment
OSCC, N = 99 | Control, N = 101 | Difference between groups | |
---|---|---|---|
Sexa, male (%) | 54 (54%) | 46 (46%) | NS |
Mean age, years (SD) | 68.0 (10.3) | 66.4 (14.3) | NS |
Smokers (%) | 43 (43%) | 8 (7.9%) | p = 1.6E-08 |
Alcohol-users (%) | 62 (62%) | 59 (59%) | NS |
Edentate (%) | 12 (12%) | 5 (5.0%) | NS |
Mean SFR ml/min (SD) | 1.3 (0.9) | 1.4 (0.8) | p = 0.036 |
Dry mouth, SFR < 0.5 ml/min (%) | 21 (21%) | 14 (14%) | NS |
Mean concentration of bacteria, 16S qPCR, ng/μl (SD) | 3.5 (3.3) | 3.0 (2.3) | NS |
Candidiasisb (%) | 42 (42%) | 40 (40%) | NS |
Mean Candida concentration, log10 (CFU/ml) (SD) | 2.3 (1.2) | 2.2 (1.2) | NS |
Mean concentration of fungi, 28S qPCR, ng/μl (SD) | 0.007 (0.02) | 0.003 (0.005) | NS |
Tumor classc | |||
T1 (%) | 46 (46%) | ||
T2–T4 (%) | 53 (53%) | ||
Stagec | |||
Stages I–II (%) | 57 (57%) | ||
Stages III–IV (%) | 42 (42%) | ||
Treatment | |||
Radiotherapy-treated (%) | 44 (44%) | ||
Chemotherapy-treated (%) | 5 (5.1%) |